One Step UTI in vitro diagnostic test REF: 3374
Published May 13, 2026 · Recall initiated: April 2, 2026
Summary
FDA records medical device Class II recall Z-2083-2026, published May 13, 2026 and initiated April 2, 2026. Recalling firm: DFI Co., Ltd.; Status: Ongoing; Reported quantity: 2423 units; Lot: UDI: 08806141303480/ Lot: 241023, 250625, 250905. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
The devices were distributed without required FDA premarket clearance or approval.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- DFI Co., Ltd.
- Distributor
- Worldwide - US Nationwide distribution in the states of FL, PA and the country of England.
- Lot
- UDI: 08806141303480/ Lot: 241023, 250625, 250905
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- Korea (the Republic of)
Related recalls
- FDAUric Acid in vitro diagnostic test REF: 31H0PMay 13, 2026
- FDAOne Step K in vitro diagnostic test REF: 81A4May 13, 2026
- FDAQUCARE Total Cholesterol in vitro diagnostic test REF: 6407May 13, 2026
- FDAOne Step P in vitro diagnostic test REF: 8194May 13, 2026
- FDAOne Step 10A in vitro diagnostic testMay 13, 2026
- FDAOne Step pH in vitro diagnostic test REF: 31I4PMay 13, 2026
Questions about this recall
Was One Step UTI in vitro diagnostic test REF: 3374 recalled?
Yes. FDA published recall Z-2083-2026 on May 13, 2026. Reported hazard: The devices were distributed without required FDA premarket clearance or approval.
What should I do if I have this product?
Voluntary: Firm initiated · Letter